Chet Bohac

Chet Bohac

Company: Macrogenics

Job title: Executive Director, Clinical Research


Showcasing Preliminary Results from a Phase I/II, FIH Study of MGC018 in Patients with Advanced Solid Tumours 11:00 am

Examine B7H3 as a target for an ADC with a duocarmycin payload Presenting a safety overview from Phase 1 Analyse efficacy from preliminary evidence of a Phase 1Read more

day: Track C - Day 2

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.